{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lyndhurst",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81189",
      "recalling_firm": "Amerigen Pharmaceuticals Inc.",
      "address_1": "9 Polito Ave Ste 900",
      "address_2": "N/A",
      "postal_code": "07071-3410",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed U.S. nationwide.",
      "recall_number": "D-0249-2019",
      "product_description": "Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDC 43975-253-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071.",
      "product_quantity": "5,232 bottles: a) 4,146 bottles; b) 1,086 bottles",
      "reason_for_recall": "Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.",
      "recall_initiation_date": "20181005",
      "center_classification_date": "20181115",
      "termination_date": "20190930",
      "report_date": "20181024",
      "code_info": "Lot #: a) 17F058A, Exp 6/19; b) 17F058B, Exp 6/19"
    }
  ]
}